CLAYAUTHO Trademark

Trademark Overview


On Friday, October 14, 2022, a trademark application was filed for CLAYAUTHO with the United States Patent and Trademark Office. The USPTO has given the CLAYAUTHO trademark a serial number of 79356230. The federal status of this trademark filing is REGISTERED as of Tuesday, May 14, 2024. This trademark is owned by Boehringer Ingelheim International GmbH. The CLAYAUTHO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention ...
clayautho

General Information


Serial Number79356230
Word MarkCLAYAUTHO
Filing DateFriday, October 14, 2022
Status700 - REGISTERED
Status DateTuesday, May 14, 2024
Registration Number7383292
Registration DateTuesday, May 14, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 5, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Thursday, December 1, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, December 1, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, December 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 9, 2022APPLICATION FILING RECEIPT MAILED
Thursday, June 22, 2023ASSIGNED TO EXAMINER
Monday, June 26, 2023NON-FINAL ACTION WRITTEN
Tuesday, June 27, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 3, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 3, 2023REFUSAL PROCESSED BY MPU
Monday, August 21, 2023REFUSAL PROCESSED BY IB
Thursday, December 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 16, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, February 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 7, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 27, 2024PUBLISHED FOR OPPOSITION
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 1, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, February 26, 2024NOTIFICATION PROCESSED BY IB
Tuesday, May 14, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, August 14, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 21, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, May 1, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, May 14, 2024REGISTERED-PRINCIPAL REGISTER